Neurosoft Bioelectronics develops minimally invasive brain interfaces to monitor and treat neurological disorders.
Neurosoft Bioelectronics has raised $7.5M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Neurosoft Bioelectronics's investors include Plug and Play, Connecticut Innovations, European Innovation Council, Kickfund, Venture Kick.
Neurosoft Bioelectronics is headquartered in Geneva, Switzerland.
Neurosoft Bioelectronics develops minimally invasive brain interfaces to monitor and treat neurological disorders.
Neurosoft Bioelectronics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurosoft Bioelectronics — Funding & Investors." VCBacked, May 20, 2026, https://www.vcbacked.co/company/neurosoft-bioelectronics. Accessed July 19, 2026.
VCBacked. (2026). Neurosoft Bioelectronics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/neurosoft-bioelectronics
{{cite web |title=Neurosoft Bioelectronics — Funding & Investors |url=https://www.vcbacked.co/company/neurosoft-bioelectronics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated